# Trading Analysis — 2026-10-29

## Portfolio Overview

| Metric | Value |
|--------|-------|
| Total Value | €9,840.15 |
| Cash | €2,771.71 (28.17%) |
| Positions | €7,068.44 |
| Total Return | **-1.60%** |
| Daily Change | +€43.27 (+0.44%) |
| Benchmark (EW) | €9,814.75 (-1.85%) |
| **Gap vs Benchmark** | **+0.25 pp** |
| Sharpe Ratio | 0.30 |
| Volatility | 4.97% |
| Max Drawdown | -1.93% |

## Daily Decision

**Regime:** Volatility normal, trend neutral — mean-reversion and trend-following opportunities both disabled by the regime filter.

**LLM Decision:** All 10 positions held. No trades executed in the evening pipeline.

**Reasoning:** Cash at ~28.2% sits comfortably inside the 15–30% target band for the NORMAL regime, so no forced deployment is required. No winner meets the strict reversal criteria (RSI > 70 AND Bollinger position > 1.1). DBA is at -4.55%, just shy of the -5% stop-loss threshold, but extremely oversold (RSI 12.3, Bollinger position -0.01) — a live override candidate should it breach. MC.PA remains in its mandatory cooldown. With a neutral tape and portfolio drawdown at only -1.60%, holding preserves optionality at zero transaction cost.

## Intraday Monitor Activity

The monitor traded once today: **AI.PA 50% profit-take at 12:18 UTC @ €179.42** (+2.96% gap at the Paris open, full Bollinger-breakout criteria met on honest bands). Realized **+€12.66**; remaining 1.4821 shares continue to run (+3.70% unrealized on the residual). Weekly discretionary budget now **2/3 used**. The evening pipeline reviewed the remainder against the surveillance escalation thresholds (RSI ≥ 82, BB position > 1.3, price > ~€183) — none triggered, so the residual holds.

## Position Highlights

| Ticker | Weight | P&L % | Note |
|--------|--------|-------|------|
| SPY | 20.74% | +3.07% | Largest position |
| TLT | 13.51% | +1.89% | Bond ETF stabilizer |
| REET | 9.50% | +1.46% | Real estate ETF |
| ^FCHI | 7.62% | +1.75% | CAC 40 index |
| DBA | 4.62% | **-4.55%** | Override watch, day 3 |
| MC.PA | 4.47% | -0.43% | In mandatory cooldown |
| IJR | 4.20% | +2.14% | Small-cap ETF |
| AI.PA | 2.67% | +3.70% | Post-trim residual |
| PDBC | 2.60% | +12.79% | Best performer |
| SAN.PA | 1.90% | +4.04% | Sanofi |

## Risk Metrics

- **CVaR 95%:** +0.65%
- **VaR 95%:** +0.49%
- **Max Drawdown:** -1.93%
- **Volatility:** 4.97% (annualized)
- **Sortino (tail block):** 1.62

## H4 Shadow Arm

Record #8: all-hold, matching the live arm exactly (10/10 tickers). Live–shadow agreement continues; no size divergence to report today.

## Observations

- **DBA override watch, day 3.** The position closed at -4.55% vs entry, roughly 0.45 pp from the -5% soft stop. The LLM pre-committed to the documented mean-reversion override should it breach (RSI 12.3 is extreme). The hard -7% threshold (~€26.47) remains the unconditional exit line — a live price below it forces a full exit without waiting for the pipeline.
- **Cash at 28.17%** — inside the band, no Rule-5 tension, but one trim away from the 30% upper edge. The AI.PA residual is the most likely next source of either cash (further trim) or stabilization.
- **Cumulative gap vs equal-weight benchmark: +0.25 pp.** The strategy's cash-heavy posture is finally paying on down days: +0.44% while the 32-asset benchmark slipped.
- Weekly discretionary budget: **2/3 used** (Monday's FEZ stop + today's AI.PA trim). One trade remains before Monday's rollover.
- Realized P&L improved from -€20.36 to **-€7.70** thanks to the AI.PA trim; unrealized stands at +€142.39.

---

*Almost surely, patience converges.* 🦀
